Skip to main content
Premium Trial:

Request an Annual Quote

MWG to Sell Microarray Genomic Dx Assets to India Informatics Shop

NEW YORK, Feb. 25 (GenomeWeb News) - Ocimum Biosolutions of Hyderabad, India, intends to acquire the assets of MWB Biotech's genomic diagnosis microarray business, the companies said in a joint statement today.

 

Ocimum, which sells LIMS and offers contract research services, is taking all assets, including inventory and stock, but not the employees of MWG's distressed microarray business. The company will relocate the business to India, while offering some services from Indianapolis, the companies said in a statement.

 

Financial details were not disclosed.

 

Earlier this month, MWG announced the sale of its lab automation business, including its Theonyx liquid-handling platform, to Greiz, Germany-based Aviso.   MWG had announced its intention to exit the automation and array business  in October.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.